Category: Diagnostic

Panacea Announces Collaboration With MIT

Panacea Pharmaceuticals, Inc. has signed a Collaborative Research Agreement with researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts covering the development of all-human, ultra-affinity, single-chain antibodies for its cancer platform technology. The research group is led by K. Dane Wittrup, Ph.D., J.R. Mares Professor of Chemical Engineering and Bioengineering at MIT. Dr. Read more about Panacea Announces Collaboration With MIT[…]

abbott laboratories

Collaborative Group And Abbott Sign License Agreement

The Collaborative Group, Ltd., and Abbott Laboratories have signed a worldwide, exclusive license agreement granting Abbott access to Collaborative’s technology relating to fungal beta (1,3)-glucan detection reagents for human fungal diagnostic assay development and commercialization. The technology allows easy integration with a variety of diagnostic assay formats, and also provides improved performance over other existing Read more about Collaborative Group And Abbott Sign License Agreement[…]